Evidence map›Paper›PMID 31456523›Full record

ArticleCurrent HIV research2019

Frailty among HIV-1 Infected Adults under Antiretroviral Therapy in Indonesia.

Wulunggono Wulunggono, Evy Yunihastuti, Hamzah Shatri, Edy Rizal Wahyudi, Youdiil Ophinni

Abstract read
In one paragraph

Article in Current HIV research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Physical Function and Frailty in HIV.Topics in antiviral medicine
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wulunggono WulunggonoDepartment of Internal Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia.
Evy YunihastutiDepartment of Internal Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia.
Hamzah ShatriDepartment of Internal Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia.
Edy Rizal WahyudiDepartment of Internal Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia.
Youdiil OphinniDepartment of Pathology, Graduate School of Medicine, Kobe University, Kobe, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIncreasing age of HIV-1 infected population brought about the risk of frailty as comorbidity, whose prevalence is higher in low and middle-income countries (LMICs). Indonesia as an LMIC also bears a major burden of HIV-1 epidemic with a similarly aging population, but the prevalence of frailty and its predictors are unknown.

objectivesTo identify the prevalence of frailty and analyze its associated factors, among HIV-1 infected adults under antiretroviral therapy in Indonesia.

methodsA cross-sectional study was conducted among HIV-infected individuals with inclusion criteria of age ≥30 years old and underwent ART for at least 6 months. The main assessment was done using Fried's frailty phenotype score, which categorizes subjects into non-frail, pre-frail, or frail. Factors associated with frailty were characterized and multiple logistic regression analysis was performed.

resultsA total of 164 subjects were recruited; male subjects were 118 (72%), the median age was 40.5 years old, and the median CD4 nadir was 53 cells/μl. Frailty was identified among 90 (54.9%) subjects with 84 (51.2%) identified as pre-frail and 6 (3.7%) as frail, with dominant frailty phenotype was weakness in grip strength. The multivariate model showed that depression was the only factor significantly correlated with pre-frailty and frailty (OR 2.14; 95% CI 1.04-4.43, p=0.036).

conclusionFrailty is a common occurrence among HIV-infected patients under ART, with depression as an independent predictive factor.

Indexed as

HIV-1AdultAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveComorbidityCross-Sectional StudiesFemaleFrailtyHIV InfectionsHumansIndonesiaMaleMiddle AgedPrevalenceRisk FactorsAnti-HIV AgentsAIDSantiretroviral therapydepressionfrailty.HIV-1LMIC

Identifiers

PMID31456523
PMCPMC7061977

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.